kinase inhibitors (TargeGen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namekinase inhibitors (TargeGen)
Drug Alias NameTG-100-598TG-100435
ClassificationSmall molecules
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitorsTyrosine-protein kinase SRC inhibitorsAngiogenesis inhibitors +[5] 
TargetsBcr-Abl tyrosine kinaseTyrosine-protein kinase SRC
Therapy Area/IndicationsEdemaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargegen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargegen Inc
Active IndicationsN/A
Inactive IndicationsEdemaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A